WELCOME TO ONCOSCIENCE

About Us

Oncoscience GmbH develops therapeutic options for rare diseases in oncology.

CLICK HERE FOR MORE INFO


ONCOLOGY

Oncology and Orphan Drugs

Cancer is one of the leading causes of death worldwide and e.g. in Germany the second leading cause of death after cardiovascular diseases.

CLICK HERE FOR MORE INFO

NEWS

Eine Publikation zeigt Nutzen bei Patienten mit lokal fortgeschrittenem oder metastasiertem Pankreas-Karzinom bei der kombinierten Behandlung mit Nimotuzumab und Gemcitabin.

Oncoscience | November 17th, 2017

Die Ergebnisse einer randomisierten Phase IIB/IIIa Studie mit der kombinierten Behandlung von Nimotuzumab und Gemcitabin...

Publication shows benefit in patients with locally advanced or metastatic pancreatic cancer treated with nimotuzumab in combination with gemcitabine.

Oncoscience | November 17th, 2017

New publication shows benefit in patients with locally advanced or metastatic pancreatic cancer treated with nimotuzumab...

legal form changed

Oncoscience | August 22nd, 2017

We are now Oncoscience GmbH. Managing directors are Dr. Dirk Reuter, Dr. Budhi Simon and Robert Ellerson....